Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein.

MLA

Li, Dandan, et al. “Long-Term Cross Immune Response in Mice Following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike MRNA and Recombinant S1 Protein.” Vaccines, vol. 11, no. 5, May 2023, p. 963. EBSCOhost, https://doi.org/10.3390/vaccines11050963.

APA

Li, D., Zhao, H., Liao, Y., Jiang, G., Cui, P., Zhang, Y., Yu, L., Fan, S., Li, H., & Li, Q. (2023). Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein. Vaccines, 11(5), 963. https://doi.org/10.3390/vaccines11050963

Chicago

Li, Dandan, Heng Zhao, Yun Liao, Guorun Jiang, Pingfang Cui, Ying Zhang, Li Yu, Shengtao Fan, Hangwen Li, and Qihan Li. 2023. “Long-Term Cross Immune Response in Mice Following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike MRNA and Recombinant S1 Protein.” Vaccines 11 (5): 963. doi:10.3390/vaccines11050963.